Current Pharmaceutical Design
Title:Editorial [ Hot Topic: Past, Present and Future in the Treatment of Major Psychotic Disorders (Executive Guest Editor: Konstantinos N. Fountoulakis)]
Volume: 18 Issue: 12
Author(s): Konstantinos N. Fountoulakis
Affiliation:
Export Options
About this article
Cite this article as:
Konstantinos N. Fountoulakis , Editorial [ Hot Topic: Past, Present and Future in the Treatment of Major Psychotic Disorders (Executive Guest Editor: Konstantinos N. Fountoulakis)], Current Pharmaceutical Design 2012; 18 (12) . https://dx.doi.org/10.2174/138161212799958602
DOI https://dx.doi.org/10.2174/138161212799958602 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Risk Factors for Delirium after Cardiac Surgery: A Review
Current Neuropharmacology Schiff Bases of Isatin: Inhibitory Potential Towards Acetylcholinesterase and Butyrylcholinesterase
Letters in Drug Design & Discovery FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Multiple Risk Factors: A Challenge in the Management of Autism
Current Pharmaceutical Design The Enigmatic Drug Binding Site for Sodium Channel Inhibitors
Current Molecular Pharmacology Leveraging on Active Site Similarities; Identification of Potential Inhibitors of Zinc-Finger and UFSP domain Protein (ZUFSP)
Current Pharmaceutical Biotechnology Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Recent Developments in CE-MS Based Metabolomics
Current Analytical Chemistry Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy
Current Alzheimer Research Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scavenger
Current Topics in Medicinal Chemistry Reactive Oxygen Species Formation by Polymorphonuclear Cells and Mononuclear Cells as a Risk Factor of Cardiovascular Diseases
Current Pharmaceutical Biotechnology Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Current Cancer Drug Targets Exposure to Enriched Environment Restores the mRNA Expression of Mineralocorticoid and Glucocorticoid Receptors in the Hippocampus and Ameliorates Depressive-like Symptoms in Chronically Stressed Rats
Current Neurovascular Research A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems
Current Pharmaceutical Design Editorial [DUI Recidivism: An Ongoing Traffic Safety Concern]
Current Drug Abuse Reviews A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets
Current Drug Targets